Beth S Slomine1, Faye S Silverstein2, James R Christensen3, Richard Holubkov4, Russell Telford4, J Michael Dean4, Frank W Moler2. 1. Kennedy Krieger Institute, 707 North Broadway, Baltimore, MD 21205, United States; Johns Hopkins University, School of Medicine, Baltimore, MD 21205, United States. Electronic address: slomine@kennedykrieger.org. 2. Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, United States. 3. Kennedy Krieger Institute, 707 North Broadway, Baltimore, MD 21205, United States; Johns Hopkins University, School of Medicine, Baltimore, MD 21205, United States. 4. Department of Pediatrics, University of Utah, 295 Chipeta Way, P. O. Box 58128, Salt Lake City, UT 84158, United States.
Abstract
AIM: Children who remain comatose after in-hospital cardiac arrest (IH-CA) resuscitation are at risk for poor neurological outcome. We report results of detailed neurobehavioural testing in paediatric IH-CA survivors, initially comatose after return of circulation, and enrolled in THAPCA-IH, a clinical trial that evaluated two targeted temperature management interventions (hypothermia, 33.0 °C or normothermia, 36.8 °C; NCT00880087). METHODS: Children, aged 2 days to <18 years, were enrolled in THAPCA-IH from 2009 to 2015; primary trial outcome (survival with favorable neurobehavioural outcome) did not differ between groups. Pre-IH-CA neurobehavioural functioning, measured with the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) was evaluated soon after enrollment; this report includes only children with broadly normal pre-IH-CA scores (VABS-II composite scores ≥70; 269 enrolled). VABS-II was re-administered 3 and 12 months later. Cognitive testing was completed at 12 months. RESULTS: Follow-ups were obtained on 125 of 135 eligible one-year survivors. Seventy-seven percent (96/125) had VABS-II scores ≥70 at 12 months; cognitive composites were ≥2SD of mean in 59%. VABS-II composite, domain, and most subdomain scores declined between pre-IH-CA and 3-month, and pre-IH-CA and 12-month assessments (composite means declined about 1 SD at 3 and 12 months, p < 0.005); 3 and 12-month scores were strongly correlated (r = 0.72, p < 0.001). CONCLUSIONS: In paediatric IH-CA survivors at high risk for unfavorable outcomes, the majority demonstrated significant declines in neurobehavioural functioning, across multiple functional domains, with similar functioning at 3 and 12 months. About three-quarters attained VABS-II functional performance composite scores within the broadly normal range.
AIM: Children who remain comatose after in-hospital cardiac arrest (IH-CA) resuscitation are at risk for poor neurological outcome. We report results of detailed neurobehavioural testing in paediatric IH-CA survivors, initially comatose after return of circulation, and enrolled in THAPCA-IH, a clinical trial that evaluated two targeted temperature management interventions (hypothermia, 33.0 °C or normothermia, 36.8 °C; NCT00880087). METHODS: Children, aged 2 days to <18 years, were enrolled in THAPCA-IH from 2009 to 2015; primary trial outcome (survival with favorable neurobehavioural outcome) did not differ between groups. Pre-IH-CA neurobehavioural functioning, measured with the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) was evaluated soon after enrollment; this report includes only children with broadly normal pre-IH-CA scores (VABS-II composite scores ≥70; 269 enrolled). VABS-II was re-administered 3 and 12 months later. Cognitive testing was completed at 12 months. RESULTS: Follow-ups were obtained on 125 of 135 eligible one-year survivors. Seventy-seven percent (96/125) had VABS-II scores ≥70 at 12 months; cognitive composites were ≥2SD of mean in 59%. VABS-II composite, domain, and most subdomain scores declined between pre-IH-CA and 3-month, and pre-IH-CA and 12-month assessments (composite means declined about 1 SD at 3 and 12 months, p < 0.005); 3 and 12-month scores were strongly correlated (r = 0.72, p < 0.001). CONCLUSIONS: In paediatric IH-CA survivors at high risk for unfavorable outcomes, the majority demonstrated significant declines in neurobehavioural functioning, across multiple functional domains, with similar functioning at 3 and 12 months. About three-quarters attained VABS-II functional performance composite scores within the broadly normal range.
Authors: Andrew L Lux; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne Journal: Lancet Neurol Date: 2005-11 Impact factor: 44.182
Authors: Frank W Moler; Kathleen Meert; Amy E Donaldson; Vinay Nadkarni; Richard J Brilli; Heidi J Dalton; Robert S B Clark; Donald H Shaffner; Charles L Schleien; Kimberly Statler; Kelly S Tieves; Richard Hackbarth; Robert Pretzlaff; Elise W van der Jagt; Fiona Levy; Lynn Hernan; Faye S Silverstein; J Michael Dean Journal: Crit Care Med Date: 2009-07 Impact factor: 7.598
Authors: Javier J Lasa; Rachel S Rogers; Russell Localio; Justine Shults; Tia Raymond; Michael Gaies; Ravi Thiagarajan; Peter C Laussen; Todd Kilbaugh; Robert A Berg; Vinay Nadkarni; Alexis Topjian Journal: Circulation Date: 2015-12-03 Impact factor: 29.690
Authors: Lennart van Zellem; Corinne Buysse; Marlous Madderom; Jeroen S Legerstee; Femke Aarsen; Dick Tibboel; Elisabeth M Utens Journal: Intensive Care Med Date: 2015-04-18 Impact factor: 17.440
Authors: James R Christensen; Beth S Slomine; Faye S Silverstein; Kent Page; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Pediatr Crit Care Med Date: 2019-06 Impact factor: 3.624
Authors: Rebecca Ichord; Faye S Silverstein; Beth S Slomine; Russell Telford; James Christensen; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Neurology Date: 2018-06-08 Impact factor: 9.910
Authors: Beth S Slomine; Faye S Silverstein; James R Christensen; Kent Page; Richard Holubkov; J Michael Dean; Frank W Moler Journal: JAMA Neurol Date: 2018-12-01 Impact factor: 18.302
Authors: Kathleen Meert; Beth S Slomine; Faye S Silverstein; James Christensen; Rebecca Ichord; Russell Telford; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Resuscitation Date: 2019-02-25 Impact factor: 5.262
Authors: Ryan W Morgan; Robert M Sutton; Adam S Himebauch; Anna L Roberts; William P Landis; Yuxi Lin; Jonathan Starr; Abhay Ranganathan; Nile Delso; Constantine D Mavroudis; Lindsay Volk; Julia Slovis; Alexandra M Marquez; Vinay M Nadkarni; Marco Hefti; Robert A Berg; Todd J Kilbaugh Journal: Resuscitation Date: 2021-03-22 Impact factor: 5.262
Authors: Ryan W Morgan; Matthew P Kirschen; Todd J Kilbaugh; Robert M Sutton; Alexis A Topjian Journal: JAMA Pediatr Date: 2021-03-01 Impact factor: 16.193
Authors: Alexis A Topjian; Bingqing Zhang; Rui Xiao; France W Fung; Robert A Berg; Kathryn Graham; Nicholas S Abend Journal: Resuscitation Date: 2021-07-05 Impact factor: 6.251
Authors: Caitlin E O'Brien; Polan T Santos; Ewa Kulikowicz; Jennifer K Lee; Raymond C Koehler; Lee J Martin Journal: BMC Neurosci Date: 2020-10-31 Impact factor: 3.288